{"denoms":[{"counts":[{"groupId":"BG000","value":"26"}],"units":"Participants"}],"groups":[{"description":"Lenalidomide 25 mg administered orally once daily (QD) until progressive disease or unacceptable toxicity.","id":"BG000","title":"Lenalidomide"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"7.20","value":"67.5"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"14"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"0 = Fully Active"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"title":"1 = Restrictive but Ambulatory"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"2 = Ambulatory but Unable to Work"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"3 = Limited Self-Care"}],"description":"ECOG performance status is used by doctors and researchers to assess how a subject's disease is progressing, assess how the disease affects the daily living activities of the subject and determine appropriate treatment and prognosis. 0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)","paramType":"NUMBER","populationDescription":"Intent to Treat population was defined as all participants who were enrolled in this study independent of whether they received lenalidomide or not.","title":"Eastern Cooperative Oncology Group (ECOG) Performance Status","unitOfMeasure":"Participants"}],"populationDescription":"Intent to treat population consisted of all participants enrolled independent of whether they received study treatment or not."}